- Home
- ONC
as 11-14-2025 3:38pm EST
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
| Founded: | 2010 | Country: | Switzerland |
| Employees: | N/A | City: | BASEL |
| Market Cap: | 34.8B | IPO Year: | N/A |
| Target Price: | $361.00 | AVG Volume (30 days): | 252.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.29 | EPS Growth: | N/A |
| 52 Week Low/High: | $170.99 - $381.50 | Next Earning Date: | 11-06-2025 |
| Revenue: | $4,998,489,124 | Revenue Growth: | 49.15% |
| Revenue Growth (this year): | 887.89% | Revenue Growth (next year): | 22.45% |
Latest BeiGene Ltd. American Depositary Shares News
ONC Breaking Stock News: Dive into ONC Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Are Shares of BeOne Medicines Attractively Priced After Recent Cancer Therapeutics Collaboration?
Simply Wall St.
3 days ago
US Stock Market Today: S&P 500 Futures Rise as Shutdown Ends, Rate Jitters Build
Investor's Business Daily
4 days ago
Stock Market Today: Dow Hits New Highs; Lilly, Barrick, Goldman Break Out (Live Coverage)
Investor's Business Daily
4 days ago
BeOne, IBD Stock Of The Day, Breaks Out As It Takes On Cancer Giants J&J, AbbVie
Investor's Business Daily
4 days ago
BeOne Medicines Stock Earns Relative Strength Rating Upgrade
MT Newswires
4 days ago
Asian Equities Traded in the US as American Depositary Receipts Advance in Wednesday Trading
Investor's Business Daily
5 days ago
Biotech Leader BeOne Medicines Eyes New Buy Point As Cancer Drug Sales Surge
GuruFocus.com
6 days ago
BeOne Medicines Ltd (ONC) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ...
Compare ONC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ONC BeiGene Ltd. American Depositary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.